Swiss National Bank Precision Biosciences Inc Transaction History

Swiss National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.15 - $3.34 $132,135 - $383,766	-114,900 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$2.96 - $7.76 $29,600 - $77,600	10,000 Added 9.53%	114,900 $354,000
Q4 2021 Feb 08, 2022	BUY	$7.4 - $11.66 $30,340 - $47,806	4,100 Added 4.07%	104,900 $776,000
Q2 2021 Aug 06, 2021	BUY	$8.07 - $12.52 $145,260 - $225,360	18,000 Added 21.74%	100,800 $1.26 Million
Q4 2020 Feb 05, 2021	BUY	$5.98 - $12.47 $14,950 - $31,175	2,500 Added 3.11%	82,800 $691,000
Q2 2020 Aug 05, 2020	BUY	$4.66 - $8.7 $374,198 - $698,610	80,300 New	80,300 $669,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $842M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.